Karbalta 30 mg 28 capsules
Mash Premiere for Pharmaceutical Industries
Mash Premiere for Pharmaceutical Industries
Composition:
Each hard gelatin capsule contains Duloxetine 30 mg in delayed-release pellets.
Product Description:
Karbalta is an antidepressant preparation containing duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI).
It is formulated as delayed-release capsules to ensure controlled absorption.
Indications for Use:
Treatment of major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, and fibromyalgia.
Method of Administration and Dosage:
Adults: 30 mg once daily, swallowed whole with water.
Dosage may be adjusted by physician depending on condition and response.
Capsules should not be crushed or chewed.
Contraindications:
Hypersensitivity to duloxetine or excipients.
Contraindicated in patients with uncontrolled hypertension, severe liver impairment, or concomitant use of MAO inhibitors.
Precautions:
Use with caution in patients with renal impairment, seizure disorders, or history of mania.
Monitor blood pressure and liver function during treatment.
Adverse Reactions (Side Effects):
Possible nausea, dry mouth, drowsiness, dizziness, constipation, sweating, or insomnia. Rare cases of liver dysfunction or suicidal ideation.
Pregnancy and Lactation:
Use only if clearly needed and prescribed by a physician;
safety data are limited.
Storage Conditions:
Store below 25°C, in a dry place, protected from light and moisture.
Packaging:
Box of 28 hard gelatin capsules.